Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures

PHASE3CompletedINTERVENTIONAL
Enrollment

239

Participants

Timeline

Start Date

August 3, 2015

Primary Completion Date

March 30, 2023

Study Completion Date

March 30, 2023

Conditions
Epilepsy
Interventions
DRUG

Lacosamide Tablet

"* Active substance: Lacosamide~* Pharmaceutical form: Tablet~* Concentration: 50 mg and 100 mg~* Route of Administration: Oral administration"

DRUG

Lacosamide Oral Solution

"* Active substance: Lacosamide~* Pharmaceutical form: Oral solution~* Concentration: 10 mg/ml~* Route of Administration: Oral administration"

Trial Locations (87)

10016

Ep0012 43, New York

32405

Ep0012 13, Panama City

33470

Ep0012 42, Loxahatchee Groves

33952

EP0012 2, Port Charlotte

53715

Ep0012 23, Madison

55422

Ep0012 25, Golden Valley

61637

Ep0012 21, Peoria

72205

EP0012 5, Little Rock

75401

Ep0012 50, Greenville

77005

Ep0012 34, Houston

78229

Ep0012 38, San Antonio

78758

Ep0012 53, Austin

80907

Ep0012 31, Colorado Springs

83702

Ep0012 15, Boise

90404

EP0012 8, Santa Monica

98057

Ep0012 27, Renton

Unknown

Ep0012 980, Chatswood

Ep0012 985, Heidelberg

Ep0012 986, Melbourne

Ep0012 981, Parkville

Ep0012 181, Curitiba

Ep0012 180, Florianópolis

Ep0012 186, Passo Fundo

Ep0012 185, Porto Alegre

Ep0012 188, Rio de Janeiro

Ep0012 183, São Paulo

Ep0012 500, Blagoevgrad

Ep0012 501, Sofia

Ep0012 971, Beijing

Ep0012 976, Changchun

Ep0012 972, Shanghai

Ep0012 550, Ostrava- Poruba

Ep0012 553, Prague

Ep0012 556, Prague

Ep0012 552, Zlín

Ep0012 255, Bron

Ep0012 252, Lille

Ep0012 251, Nancy

Ep0012 303, Erlangen

Ep0012 314, Freiburg im Breisgau

Ep0012 311, Marburg

Ep0012 600, Budapest

Ep0012 603, Szeged

Ep0012 850, Rehovot

Ep0012 851, Tel Litwinsky

Ep0012 351, Torino

Ep0012 906, Fukuoka

Ep0012 910, Gifu

Ep0012 903, Hamamatsu

Ep0012 902, Hiroshima

Ep0012 912, Kagoshima

Ep0012 914, Kodaira

Ep0012 909, Kokubunji-shi

Ep0012 901, Niigata

Ep0012 911, Omura-shi

Ep0012 900, Sapporo

Ep0012 908, Shinjuku-ku

Ep0012 161, Guadalajara

Ep0012 657, Częstochowa

Ep0012 655, Gdansk

Ep0012 652, Gliwice

Ep0012 651, Katowice

Ep0012 653, Katowice

Ep0012 654, Katowice

Ep0012 656, Tyniec Mały

Ep0012 650, Warsaw

Ep0012 659, Warsaw

Ep0012 451, Lisbon

Ep0012 704, Iași

Ep0012 700, Timișoara

Ep0012 750, Kazan'

Ep0012 758, Pyatigorsk

Ep0012 755, Saint Petersburg

Ep0012 756, Saint Petersburg

Ep0012 752, Samara

Ep0012 757, Yekaterinburg

Ep0012 821, Bardejov

Ep0012 823, Hlohovec

Ep0012 940, Daegu

Ep0012 941, Seoul

Ep0012 944, Seoul

Ep0012 402, Barcelona

Ep0012 406, Córdoba

Ep0012 407, Madrid

Ep0012 403, Seville

Ep0012 961, Taichung

Ep0012 960, Taipei

All Listed Sponsors
lead

UCB BIOSCIENCES, Inc.

INDUSTRY

NCT02408549 - Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures | Biotech Hunter | Biotech Hunter